MicroGenDX

MicroGenDX is a leading biotechnology research company specializing in accurate microbial identification through Next Generation DNA Sequencing. With a strong commitment to advancing diagnostic capabilities, MicroGenDX provides qPCR+NGS sequencing for the detection of infectious diseases. Recognized by the American Medical Association (AMA) and Medicare with a specific billing code, MicroGenDX's technology is deemed medically necessary, highlighting its importance in modern healthcare. The primary address for MicroGenDX is 5786 Hoffner Ave, Orlando, Florida 32822, US.

Trusted by over 39,000 physicians worldwide and having aided over 900,000 patients, MicroGenDX delivers diagnostic testing solutions for chronic and life-threatening infections. As a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory, MicroGenDX maintains the highest standards of quality and precision. The advanced NGS technology employed by MicroGenDX offers significant advantages over traditional culture-based methods, detecting a wider range of microorganisms with greater accuracy and speed.

MicroGenDX's testing services are utilized in diverse healthcare environments, including hospitals, long-term care facilities, dental offices, and veterinary clinics. The technology is applied to various clinical conditions, such as chronic wounds, orthopedic infections, respiratory infections, and urinary tract infections. We invite the manager of MicroGenDX to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development.